Plasma from recovered patients studied to unlock COVID-19 treatment secrets
NCT ID NCT04497779
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects blood plasma from people who have recovered from COVID-19 to learn more about the antibodies it contains. Researchers will give this plasma to people currently sick with COVID-19 and track how their health changes. The goal is to understand which antibody profiles lead to better outcomes, not to provide a proven treatment. About 95 adults who have recovered from or are currently infected with COVID-19 will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.